Literature DB >> 26320195

Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.

Eric Plitman1, Camilo de la Fuente-Sandoval2, Francisco Reyes-Madrigal3, Sofia Chavez4, Gladys Gómez-Cruz3, Pablo León-Ortiz5, Ariel Graff-Guerrero6.   

Abstract

Glial disturbances are highly implicated in the pathophysiology of schizophrenia and may be linked with glutamatergic dysregulation. Myo-inositol (mI), a putative marker of glial cells, and choline (Cho), representative of membrane turnover, are both present in larger concentrations within glial cells than in neurons, and their elevation is often interpreted to reflect glial activation. Proton magnetic resonance spectroscopy ((1)H-MRS) allows for the evaluation of mI, Cho, glutamate, glutamate + glutamine (Glx), and N-acetylaspartate (NAA). A collective investigation of these measures in antipsychotic-naive patients experiencing their first nonaffective episode of psychosis (FEP) can improve the understanding of glial dysfunction and its implications in the early stages of schizophrenia. 3-Tesla (1)H-MRS (echo time = 35 ms) was performed in 60 antipsychotic-naive patients with FEP and 60 age- and sex-matched healthy controls. mI, Cho, glutamate, Glx, and NAA were estimated using LCModel and corrected for cerebrospinal fluid composition within the voxel. mI, Cho, and glutamate were elevated in the FEP group. After correction for multiple comparisons, mI positively correlated with grandiosity. The relationships between mI and glutamate, and Cho and glutamate, were more positive in the FEP group. These findings are suggestive of glial activation in the absence of neuronal loss and may thereby provide support for the presence of a neuroinflammatory process within the early stages of schizophrenia. Dysregulation of glial function might result in the disruption of glutamatergic neurotransmission, which may influence positive symptomatology in patients with FEP.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MRS; astrocyte; glutamatergic; neuroinflammation; positive symptoms; schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26320195      PMCID: PMC4753594          DOI: 10.1093/schbul/sbv118

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  89 in total

1.  Treatment refractory schizophrenia.

Authors:  J P Lindenmayer
Journal:  Psychiatr Q       Date:  2000

2.  High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia.

Authors:  Juan R Bustillo; Laura M Rowland; John Lauriello; Helen Petropoulos; Roger Hammond; Blaine Hart; William M Brooks
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

3.  In reply.

Authors:  Nina V Kraguljac; Gary R Cutter; Charity Morgan; Adrienne C Lahti
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

4.  Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.

Authors:  T Fujimoto; T Nakano; T Takano; K Takeuchi; K Yamada; T Fukuzako; H Akimoto
Journal:  Biol Psychiatry       Date:  1996-07-01       Impact factor: 13.382

5.  Specific glial functions contribute to schizophrenia susceptibility.

Authors:  Andrea Goudriaan; Christiaan de Leeuw; Stephan Ripke; Christina M Hultman; Pamela Sklar; Patrick F Sullivan; August B Smit; Danielle Posthuma; Mark H G Verheijen
Journal:  Schizophr Bull       Date:  2013-08-16       Impact factor: 9.306

6.  Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.

Authors:  Ariel Graff-Guerrero; Matthaeus Willeit; Nathalie Ginovart; David Mamo; Romina Mizrahi; Pablo Rusjan; Irina Vitcu; Philip Seeman; Alan A Wilson; Shitij Kapur
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

7.  Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.

Authors:  Dan Shan; Elizabeth K Lucas; Jana B Drummond; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2013-01-26       Impact factor: 4.939

8.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Authors:  Jean Théberge; Yousef Al-Semaan; Peter C Williamson; Ravi S Menon; Richard W J Neufeld; Nagalingam Rajakumar; Betsy Schaefer; Maria Densmore; Dick J Drost
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

9.  Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy.

Authors:  Julian L Griffin; Mary Bollard; Jeremy K Nicholson; Kishore Bhakoo
Journal:  NMR Biomed       Date:  2002-10       Impact factor: 4.044

10.  Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia.

Authors:  Naoki Goto; Reiji Yoshimura; Shingo Kakeda; Joji Nishimura; Junji Moriya; Kenji Hayashi; Asuka Katsuki; Hikaru Hori; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Yukunori Korogi; Jun Nakamura
Journal:  Neuropsychiatr Dis Treat       Date:  2012-04-03       Impact factor: 2.570

View more
  30 in total

1.  Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia.

Authors:  Lauren V Moran; Luke E Stoeckel; Kristina Wang; Carolyn E Caine; Rosemond Villafuerte; Vanessa Calderon; Justin T Baker; Dost Ongur; Amy C Janes; A Eden Evins; Diego A Pizzagalli
Journal:  Psychopharmacology (Berl)       Date:  2017-11-27       Impact factor: 4.530

2.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.

Authors:  Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

Review 3.  Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders.

Authors:  Jennifer H Foss-Feig; Brendan D Adkinson; Jie Lisa Ji; Genevieve Yang; Vinod H Srihari; James C McPartland; John H Krystal; John D Murray; Alan Anticevic
Journal:  Biol Psychiatry       Date:  2017-03-14       Impact factor: 13.382

Review 4.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Eric Plitman; Yusuke Iwata; Fernando Caravaggio; Shinichiro Nakajima; Jun Ku Chung; Philip Gerretsen; Julia Kim; Hiroyoshi Takeuchi; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

5.  Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Authors:  Wei-Wei Li; Yan Yang; Qi-Gang Dai; Li-Li Lin; Tong Xie; Li-Li He; Jia-Lei Tao; Jin-Jun Shan; Shou-Chuan Wang
Journal:  Metabolomics       Date:  2018-06-21       Impact factor: 4.290

6.  Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.

Authors:  Camilo de la Fuente-Sandoval; Francisco Reyes-Madrigal; Xiangling Mao; Pablo León-Ortiz; Oscar Rodríguez-Mayoral; Helgi Jung-Cook; Rodolfo Solís-Vivanco; Ariel Graff-Guerrero; Dikoma C Shungu
Journal:  Biol Psychiatry       Date:  2017-10-10       Impact factor: 13.382

7.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11 C]-raclopride and [11 C]-(+)-PHNO PET.

Authors:  Fernando Caravaggio; Jun Ku Chung; Eric Plitman; Isabelle Boileau; Philip Gerretsen; Julia Kim; Yusuke Iwata; Raihaan Patel; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Hum Brain Mapp       Date:  2017-07-28       Impact factor: 5.038

8.  Role of glia in prefrontal white matter abnormalities in first episode psychosis or mania detected by diffusion tensor spectroscopy.

Authors:  Kathryn E Lewandowski; Fei Du; Xiaoying Fan; Xi Chen; Polly Huynh; Dost Öngür
Journal:  Schizophr Res       Date:  2019-05-14       Impact factor: 4.939

9.  Relationship of auditory electrophysiological responses to magnetic resonance spectroscopy metabolites in Early Phase Psychosis.

Authors:  Lisa A Bartolomeo; Andrew M Wright; Ruoyun E Ma; Tom A Hummer; Michael M Francis; Andrew C Visco; Nicole F Mehdiyoun; Amanda R Bolbecker; William P Hetrick; Ulrike Dydak; John Barnard; Brian F O'Donnell; Alan Breier
Journal:  Int J Psychophysiol       Date:  2019-05-23       Impact factor: 2.997

Review 10.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.